Author of the publication

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

, , , , , , , , , , , , , , , and . Lancet, 359 (9323): 2065–2071 (2002)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial, , , , , , , , , and 21 other author(s). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 15 (2): 276–282 (2004)Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial, , , , , , , , , and 6 other author(s). Lancet, 359 (9323): 2065–2071 (2002)Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5, , , , , , , , , and 16 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 (2): 476–484 (2002)A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly), , , , , , , , , and 5 other author(s). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 16 (1): 124–131 (2005)Qualitätsmanagement in Therapieoptimierungsstudien der Deutschen Hodgkin Lymphom Studiengruppe (DHSG), , , , , and . Der Onkologe, 6 (12): 1202–1204 (2000)